No, wasn't me. However, I am working to reach a 2M position in Todos Medical. If the Tollovir interim trial data nearing release is good, AMBS shareholders should see some benefit as well as TOMDF.

I no longer hold any AMBS shares, but believe those still holding will benefit by what is happening with Todos.

In the words of Captain James T. Kirk, "May fortune favor the foolish." (Star Trek IV)